REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bosmed Sp. z o.o. sp. k. (Poland)

Main Activities: Grain and Field Bean Merchant Wholesalers | Farm Supplies Merchant Wholesalers
Secondary Activities: Merchant Wholesalers, Durable Goods | Retail Trade | Pipeline Transportation | Educational Services
Full name: Bosmed Sp. z o.o. sp. k. Profile Updated: September 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Bosmed Sp. z o.o. sp. k is a livestock and dairy production company. The company offers a range of products aimed at improving the health and condition of cows, supporting dairy farmers, and enhancing milk production. Their products include GoldMint, Bufor, HepaShot, Travimed, Calf Plus, MilkMed, Pectopect, and Mykostop.

Headquarters
Falatycze 38
Falatycze; Mazowieckie; Postal Code: 08-210

Contact Details: Purchase the Bosmed Sp. z o.o. sp. k. report to view the information.

Website: http://www.bosmed.pl

Basic Information
Outstanding Shares:
Purchase the Bosmed Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
January 23, 2020
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Bosmed Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
28.49%▲
Total operating revenue
29.94%▲
Operating profit (EBIT)
26.8%▲
EBITDA
14.4%▲
Net Profit (Loss) for the Period
27.71%▲
Total assets
164.46%▲
Total equity
N/A
Operating Profit Margin (ROS)
-0.22%▼
Net Profit Margin
-0.09%▼
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo